Banmeet Anand
Corporate Officer/Principal at HARPOON THERAPEUTICS, INC.
Banmeet Anand active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 05/07/2022 | - |
Career history of Banmeet Anand
Former positions of Banmeet Anand
| Companies | Position | Start | End |
|---|---|---|---|
| MOLECULAR TEMPLATES, INC. | Corporate Officer/Principal | - | - |
Training of Banmeet Anand
| University of Missouri | Doctorate Degree |
Statistics
International
| United States | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Banmeet Anand
- Experience